Literature DB >> 2835201

Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay.

M J Gilchrist1, T S Bretl, K Moultney, D R Knowlton, R L Ward.   

Abstract

A sensitive, specific enzyme immunoassay (SSEIA) was compared to four commercial, enzyme-linked immunosorbent assay (ELISA) kits and three latex agglutination assay (LAA) kits: (1) Rotavirus EIA, International Diagnostic Laboratories (IDL), (2) Pathfinder, Kallestadt (KAL), (3) Rotavirus Bio-EnzaBead, Litton (LIT), (4) Rotazyme II, Abbott (RTZII), (5) Slidex Rota-Kit, bioMerieux (SRK), (6) Meritec-Rotavirus, Meridian (MER), and (7) Rotalex, Medical Technology Corporation (RLX). The SSEIA was chosen as the reference method due to its greater sensitivity in comparison to immunoelectron microscopy and polyacrylamide gel electrophoreses of viral RNA segments. Upon evaluation of 136 specimens (of which 44 were positive by SSEIA), the ELISA kits (LIT, KAL, IDL, and RTZII) had sensitivities of 80%, 98%, 91% and 84%; specificities of 95%, 78%, 100%, and 88%; positive predictive values (PPV) of 88%, 68%, 100%, and 77%; and negative predictive values (NPV) of 91%, 99%, 96%, and 92%. When compared with SSEIA, the three LAA tests (SRK, MER, and RLX) had sensitivities of 73%, 75%, and 62%; specificities of 99%, 93%, and 95%; PPVs of 97%, 85%, and 84%; and NPVs of 88%, 89%, and 84%. LAA test results appeared to be reliable, if positive, but the sensitivities of these tests were less than those of the ELISA tests. The ELISA tests that employed specimen specific negative controls were superior in minimizing false positive reactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2835201     DOI: 10.1016/0732-8893(87)90053-8

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Evaluation of the ImmunoCardSTAT! rotavirus assay for detection of group A rotavirus in fecal specimens.

Authors:  P H Dennehy; M Hartin; S M Nelson; S F Reising
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Authors:  David O Matson; Timo Vesikari; Penelope Dennehy; Michael D Dallas; Michelle G Goveia; Robbin F Itzler; Max Ciarlet
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Comparison of nine commercial immunoassays for the detection of rotavirus in fecal specimens.

Authors:  P H Dennehy; D R Gauntlett; W E Tente
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

4.  VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina.

Authors:  M H Argüelles; G A Villegas; A Castello; A Abrami; P D Ghiringhelli; L Semorile; G Glikmann
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Evaluation of an automated immunodiagnostic assay, VIDAS Rotavirus, for detection of rotavirus in fecal specimens.

Authors:  P H Dennehy; T E Schutzbank; G M Thorne
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Choice of reference assay for the detection of rotavirus in fecal specimens: electron microscopy versus enzyme immunoassay.

Authors:  P H Dennehy; D R Gauntlett; S E Spangenberger
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults.

Authors:  María C Jaimes; Olga Lucía Rojas; Ana María González; Isabela Cajiao; Annie Charpilienne; Pierre Pothier; Evelyne Kohli; Harry B Greenberg; Manuel A Franco; Juana Angel
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Detection of group A rotavirus by reverse transcriptase and polymerase chain reaction in feces from children with acute gastroenteritis.

Authors:  M Husain; P Seth; S Broor
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study.

Authors:  Martin Sénécal; Marc Brisson; Marc H Lebel; John Yaremko; Richard Wong; Lee Ann Gallant; Hartley A Garfield; Darryl J Ableman; Richard L Ward; John S Sampalis; James A Mansi
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

10.  Opportunities for rapid viral diagnosis.

Authors:  Terrance A Bruner; Daniel P Fedorko
Journal:  Clin Microbiol Newsl       Date:  2002-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.